Art

J-GLOBAL ID：202102273716316790   Reference number：21A2822861

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

GLP-1受容体作動薬:膵臓効果を越えて【JST・京大機械翻訳】

Author (9)： Zhao Xin (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Wang Minghe (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Wen Zhitong (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Lu Zhihong (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Cui Lijuan (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Fu Chao (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Xue Huan (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China) ,  Liu Yunfeng (2Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, China) ,  Zhang Yi (1Department of Pharmacology, Shanxi Medical University, Taiyuan, China)
Material： Frontiers in Endocrinology (Web)
Volume： 12  Page： 721135  Publication year： 2021 
JST Material Number： U7068A  ISSN： 1664-2392  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Glucagon like peptide-1 (GLP-1...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A2822861&from=J-GLOBAL&jstjournalNo=U7068A") }}

Thesaurus term： tumor ,  *receptor ,  metabolic regulation ,  side effect ,  appetite ,  internal secretion ,  cardiovascular system ,  prognosis ,  Langerhans islet ,  type 2 diabetes mellitus ,  gastric emptying
Semi thesaurus term： *アゴニスト ,  インクレチン ,  *グルカゴン様ペプチド-1 ,  インスリン分泌細胞 , 【Automatic Indexing@JST】

Author keywords (5)： GLP-1 receptor agonists ,  endocrine ,  cardiovascular ,  neurological ,  cancer

JST classification (5)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of drugs acting on carbohydrate metabolism  (GW13030B) ,  Other hormones of verterbrates  (EB08070K) ,  Drugs acting on metabolism in general  (GW13010F) ,  Metabolic diseases,nutritional diseases in general.  (GD05010J)

Reference (233)：

• Graaf Cd, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, et al. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. Pharmacol Rev (2016) 68(4):954-1013. doi: doi: 10.1124/pr.115.011395
• Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes - State-of-the-Art. Mol Metab (2021) 46:101102. doi: doi: 10.1016/j.molmet.2020.101102
• Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-Like Peptide-1. Cell Metab (2018) 27(4):740-56. doi: doi: 10.1016/j.cmet.2018.03.001
• Isaacs D, Prasad-Reddy L, Srivastava SB. Role of Glucagon-Like Peptide 1 Receptor Agonists in Management of Obesity. Am J Health Syst Pharm (2016) 73(19):1493-507. doi: doi: 10.2146/ajhp150990
• Hirsch IB. The Future of the GLP-1 Receptor Agonists. JAMA (2019) 321(15):1457-8. doi: doi: 10.1001/jama.2019.2941

Terms in the title (2)： GLP-1受容体作動薬 ,  膵臓